Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Long Term Extension Study of MT-8554 in Postmenopausal Women Experiencing Moderate to Severe Vasomotor Symptoms Who Completed Study MT-8554-A01

NCT03541200 is registered in ClinicalTrials.gov with Tanabe Pharma America, Inc. as lead sponsor.

NCT NCT03541200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03541200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Long Term Extension Study of MT-8554 in Postmenopausal Women Experiencing Moderate to Severe Vasomotor Symptoms Who Completed Study MT-8554-A01
Lead sponsor
Tanabe Pharma America, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 18, 2018
Completion date
November 15, 2019
Enrollment
190 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

vasomotor symptoms (vms)